logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Sawhney, Sunjeet
    Born in May 1978
    Individual (5 offsprings)
    Officer
    icon of calendar 2021-11-16 ~ now
    OF - Director → CIF 0
  • 2
    Parekh, Rajesh
    Born in July 1960
    Individual (2 offsprings)
    Officer
    icon of calendar 2021-11-16 ~ now
    OF - Director → CIF 0
Ceased 1
  • icon of addressTerkko Health Hub, Haartmaninkatu 4, Helsinki, Finland
    Corporate
    Officer
    2021-11-16 ~ 2021-11-16
    PE - Director → CIF 0
parent relation
Company in focus

RAPPTA THERAPEUTICS (UK) LTD

Standard Industrial Classification
96090 - Other Service Activities N.e.c.
Brief company account
Average Number of Employees
22023-12-01 ~ 2024-11-30
22022-12-01 ~ 2023-11-30
Debtors
Current
1,580,056 GBP2024-11-30
1,082,306 GBP2023-11-30
Cash at bank and in hand
72 GBP2024-11-30
205,155 GBP2023-11-30
Current Assets
1,580,128 GBP2024-11-30
1,287,461 GBP2023-11-30
Creditors
Current, Amounts falling due within one year
-1,229,746 GBP2023-11-30
Net Current Assets/Liabilities
82,569 GBP2024-11-30
57,715 GBP2023-11-30
Total Assets Less Current Liabilities
82,569 GBP2024-11-30
57,715 GBP2023-11-30
Net Assets/Liabilities
82,569 GBP2024-11-30
57,715 GBP2023-11-30
Equity
Called up share capital
100 GBP2024-11-30
100 GBP2023-11-30
Retained earnings (accumulated losses)
82,469 GBP2024-11-30
57,615 GBP2023-11-30
Equity
82,569 GBP2024-11-30
57,715 GBP2023-11-30
Prepayments/Accrued Income
Current
1,580,056 GBP2024-11-30
1,082,306 GBP2023-11-30
Amounts owed to group undertakings
Current
1,326,455 GBP2024-11-30
1,177,524 GBP2023-11-30
Corporation Tax Payable
Current
14,217 GBP2024-11-30
14,614 GBP2023-11-30
Taxation/Social Security Payable
Current
72,504 GBP2024-11-30
18,252 GBP2023-11-30
Other Creditors
Current
71,171 GBP2024-11-30
Accrued Liabilities/Deferred Income
Current
13,212 GBP2024-11-30
19,356 GBP2023-11-30
Creditors
Current
1,497,559 GBP2024-11-30
1,229,746 GBP2023-11-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2024-11-30
100 shares2023-11-30
Par Value of Share
Class 1 ordinary share
1.002023-12-01 ~ 2024-11-30

  • RAPPTA THERAPEUTICS (UK) LTD
    Info
    Registered number 13746464
    icon of addressEighth Floor 6 New Street Square, New Fetter Lane, London EC4A 3AQ
    PRIVATE LIMITED COMPANY incorporated on 2021-11-16 (4 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2024-11-15
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.